Mechanism of GLP-1 Receptor Agonists-Mediated Attenuation of Palmitic Acid-Induced Lipotoxicity in L6 Myoblasts
Mo-wei Kong et al, 2022, BioMed Research International CrossRef
Dysregulated autophagy: A key player in the pathophysiology of type 2 diabetes and its complications
Abhishek Sehrawat et al, 2023, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
Autophagy in metabolic disease and ageing
Munehiro Kitada et al, 2021, Nature Reviews Endocrinology CrossRef
Protective effects of Stevia rebaudiana extracts on beta cells in lipotoxic conditions
Marco Bugliani et al, 2022, Acta Diabetologica CrossRef
LncRNA MEG3 regulates autophagy and pyroptosis via FOXO1 in pancreatic β-cells
Xiudan Li et al, 2022, Cellular Signalling CrossRef
The role of autophagy in the treatment of type II diabetes and its complications: a review
Xuan Zhao et al, 2023, Frontiers in Endocrinology CrossRef
Autophagy, Pyroptosis and Ferroptosis are Rising Stars in the Pathogenesis of Diabetic Nephropathy
Xiudan Li et al, 2024, Diabetes, Metabolic Syndrome and Obesity CrossRef
Mechanisms of Beta-Cell Apoptosis in Type 2 Diabetes-Prone Situations and Potential Protection by GLP-1-Based Therapies
Safia Costes et al, 2021, International Journal of Molecular Sciences CrossRef
β Cell and Autophagy: What Do We Know?
Hamid-Reza Mohammadi-Motlagh et al, 2023, Biomolecules CrossRef
FoxO1 as a tissue-specific therapeutic target for type 2 diabetes
Nicole A. Teaney et al, 2023, Frontiers in Endocrinology CrossRef
LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases
Zining Li et al, 2022, Frontiers in Pharmacology CrossRef
The inhibition of FKBP5 protects β-cell survival under inflammation stress via AKT/FOXO1 signaling
Na Liu et al, 2023, Cell Death Discovery CrossRef
Drosophila melanogaster: A Powerful Tiny Animal Model for the Study of Metabolic Hepatic Diseases
Karen C. M. Moraes et al, 2021, Frontiers in Physiology CrossRef